Article ID Journal Published Year Pages File Type
10817866 Clinical Biochemistry 2012 4 Pages PDF
Abstract
► Ovarian cancer (OvCa) is the most lethal gynecological malignacy. ► No adequate screening or diagnostic tools exist for early stage OvCa diagnosis. ► CUZD1 appears to be a highly promising novel serological biomarker for OvCa. ► CUZD1 may be a biomarker for breast and lung cancer.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , , ,